CD1D and cancer: Our data compliment previous findings to confirm that humanized γδ T cells expressing γδ TCR receptors may have a high affinity for human cancer cells and the CD1d-αGalCer complex, generating a robust cytotoxic effect [7,8,9,10,11,12,14,17,20,33].